Aton Ra Partners Schrodinger, Inc. Transaction History

Aton Ra Partners

$50.1 Million
Q4 2023

A detailed history of Aton Ra Partners transactions in Schrodinger, Inc. stock. As of the latest transaction made, Aton Ra Partners holds 21,486 shares of SDGR stock, worth $414,464. This represents 1.53% of its overall portfolio holdings.

Number of Shares

21,486

Previous 24,122 10.93%

Holding current value

$414,464

Previous $681,000 12.92%

% of portfolio

1.53%

Previous 1.43%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	SELL	$21.62 - $37.21 $56,990 - $98,085	-2,636 Reduced 10.93%	21,486 $769,000
Q3 2023 Oct 25, 2023	SELL	$27.34 - $55.37 $142,085 - $287,757	-5,197 Reduced 17.73%	24,122 $681,000
Q2 2023 Jul 18, 2023	SELL	$26.1 - $49.92 $85,164 - $162,888	-3,263 Reduced 10.01%	29,319 $1.46 Million
Q1 2023 May 05, 2023	SELL	$18.09 - $27.61 $162,014 - $247,275	-8,956 Reduced 21.56%	32,582 $857,000
Q4 2022 Feb 02, 2023	SELL	$16.24 - $26.38 $222,179 - $360,904	-13,681 Reduced 24.78%	41,538 $776,000
Q3 2022 Nov 14, 2022	BUY	$23.95 - $34.71 $24,117 - $34,952	1,007 Added 1.86%	55,219 $1.38 Million
Q2 2022 Aug 15, 2022	BUY	$21.39 - $35.9 $340,443 - $571,384	15,916 Added 41.56%	54,212 $1.43 Million
Q1 2022 May 16, 2022	BUY	$24.84 - $36.12 $9,439 - $13,725	380 Added 1.0%	38,296 $1.31 Million
Q4 2021 Feb 14, 2022	SELL	$33.38 - $59.25 $302,623 - $537,160	-9,066 Reduced 19.3%	37,916 $1.32 Million
Q3 2021 Nov 15, 2021	BUY	$53.75 - $76.55 $86,430 - $123,092	1,608 Added 3.54%	46,982 $2.57 Million
Q2 2021 Aug 12, 2021	BUY	$59.02 - $78.8 $488,980 - $652,858	8,285 Added 22.34%	45,374 $3.43 Million
Q1 2021 May 17, 2021	BUY	$64.61 - $113.09 $2.4 Million - $4.19 Million	37,089 New	37,089 $2.83 Million

Others Institutions Holding SDGR

# of Institutions

233

Shares Held

60.7M

Call Options Held

726K

Put Options Held

329K

View Full List

About Schrodinger, Inc.

Ticker SDGR
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 62,028,400
Market Cap $1.2B
Description
Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences i...

More about SDGR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aton Ra Partners, based on Form 13F filings with the SEC.

News

Stay updated on Aton Ra Partners with notifications on news.

Account